MeMed
PrivateLast Round
VC Round
Jan 10, 2022
Total Funding Raised
$98.03M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MeMed operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a VC Round in January 2022.
MeMed is a healthcare technology company that develops immuno-personalized diagnostic devices to rapidly identify bacterial and viral infections by analyzing patients' immune responses, thereby assisting physicians in making informed antibiotic treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MeMed Comparables
Compare MeMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inflammatix | 91% | |
| Lumos Diagnostics Holdings Limited | 82% | |
| Biomeme | 81% |
For institutional investors. Book with your work email.
MeMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 10, 2022 | ||||
| Grant | Nov 13, 2019 | ||||
| Series C | Sep 20, 2018 | ||||
| Grant | Feb 6, 2018 | ||||
| Grant | Apr 19, 2017 | ||||
Grant | Sep 18, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MeMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series B, Series C, VC Round |
| European Innovation Council Fund | Grant |
| Union Tech Ventures | VC Round |
| European Commission (Horizon Europe) | Grant |
| Clal Insurance | Series C |
| S28 Capital | Series C |
| Touchwood Capital | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 62% MoM.
- Mar 1, 2026
Developing a next-generation AIVD product.
For institutional investors. Book with your work email.
MeMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MeMed's valuation, stock price, and market status.
Is MeMed a public or private company?
MeMed is a private company.
What is the current stock price of MeMed?
MeMed is a private company, so its shares have no public market price. Caplight tracks MeMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MeMed worth (valuation)?
Valuation information for MeMed is not publicly available.
Can I buy MeMed stock?
MeMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MeMed's last funding round?
MeMed's most recent funding round was VC Round on January 10, 2022.
Who are the main investors in MeMed?
Key investors in MeMed include Horizons Ventures, Union Tech Ventures, Poalim Equity.
Will MeMed IPO soon?
No public IPO plans have been announced for MeMed.
How can I track MeMed secondary market activity?
Caplight tracks bids, offers, and trades in MeMed's shares on secondary markets.